Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Nanomix Corporation (NNMX : OTC)
 
 • Company Description   
Nanomix Corporation is involved in the development of mobile, affordable, point-of-care diagnostics. The company's products are designed to impact healthcare delivery by bringing diagnostics to the point of initial patient interaction, whether in the hospital or in pre-hospital, remote or alternate-care settings. Nanomix Corporation, formerly known as Boston Therapeutics Inc., is based in EMERYVILLE, Calif.

Number of Employees: 25

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.23 Daily Weekly Monthly
20 Day Moving Average: 496 shares
Shares Outstanding: 46.20 (millions)
Market Capitalization: $56.60 (millions)
Beta: -0.26
52 Week High: $17.30
52 Week Low: $1.23
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -19.93% -9.00%
12 Week -78.79% -77.16%
Year To Date -60.75% -52.32%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2121 Williams Street
-
San Leandro,CA 94577
USA
ph: 510-428-5300
fax: 603-685-4784
info@nano.com http://www.nano.com
 
 • General Corporate Information   
Officers
Conroy Chi-Heng Cheng - Chief Executive Officer and Chief Financial Office
Conroy Chi-Heng Cheng - Director
S. Colin Neill - Director
Conroy Chi-Heng Cheng - Director
S. Colin Neill - Director

Peer Information
Nanomix Corporation (CHCR)
Nanomix Corporation (ESRX)
Nanomix Corporation (MYDP)
Nanomix Corporation (GBCS)
Nanomix Corporation (LAXAF)
Nanomix Corporation (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 63008H201
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/16/22
Share - Related Items
Shares Outstanding: 46.20
Most Recent Split Date: 3.00 (0.01:1)
Beta: -0.26
Market Capitalization: $56.60 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/16/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 95.65%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -100.00%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -470.11
12/31/21 - -454.20
09/30/21 - -1,027.16
Current Ratio
03/31/22 - 0.03
12/31/21 - 0.14
09/30/21 - 0.69
Quick Ratio
03/31/22 - -
12/31/21 - 0.14
09/30/21 - 0.69
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -6,675.93
09/30/21 - -2,225,763.75
Book Value
03/31/22 - -0.18
12/31/21 - -4.09
09/30/21 - -3.68
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©